Recombinant protein advancements revolutionize assay development
Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research
Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research
Communication, engagement and promotion in a modern world — Terry Taylor, past president of The New Zealand Institute of Medical Laboratory Science (Inc.) shares his views in this guest editorial
Guest editorial by Susan Dawson, retired laboratory leader and founder of Accomplish More Consulting Services (AMCS)
Pioneering the future of laboratory medicine with AI-driven diagnostics
The system’s unique technology utilizes microfluidics and live imaging to monitor bacterial growth across a linear antibiotic gradient
In this guest editorial, Chris Cotreau dives into the shifting landscape of lab informatics, comparing cloud and on-premises systems, and what it means for hospital QC labs
Dr. Vasiliki Kalodimou, CLINICAL24 Ambassador, shares how her team is advancing regenerative medicine while embracing new technologies to accelerate discoveries.
In this guest blog, discover why verifying new testing systems is essential for ensuring accuracy and reproducibility when introducing innovative methods into your lab
Explore the shifting landscape of antimicrobial resistance and Group B Streptococcus in this expert-led guest blog
In this guest editorial, Eric Morreale, PhD explores global reflex testing trends, strategies, and evolving policies
Reimagining clinical microbiology with key technologies and long-acting therapies
New Panther Fusion Gastrointestinal Bacterial and Expanded Bacterial Assays deliver tailored, actionable diagnostic results to support fast and informed patient care
SVP Karan Arora shares how advanced assays, AI, and pharma partnerships are shaping the future of targeted oncology care
Championing biomedical science, combating antimicrobial resistance, and inspiring future generations in Africa
Joint consensus recommendation includes organizational representation from AMP, ASCO and CAP
This tool will be launched as part of Roche’s new chronic kidney disease algorithm panel to support care across the stages of the disease which affects 700 million people globally
An exclusive interview with Dr. Benjamin Lilienfeld on advancements, precision, and personalized care in vitamin D testing
Quanterix Director of Medical Affairs discusses the advances revolutionizing Alzheimer’s diagnosis and care
Swedish company, which speeds up prostate cancer diagnosis, chooses Milton Park for its first UK laboratory
Explore advances in lab testing methods moving food allergy diagnosis beyond skin pricks and into molecular precision
The fusion of technology and empathy in modern laboratory medicine
ClearNote Health gains in vitro diagnostic approval in the UK for its Avantect Multi-Cancer Detection Test and its Avantect Ovarian Cancer Test
The QUICKVUE Influenza + SARS test is designed for professional use to detect and differentiate between flu A/B and COVID-19 in 10–15 minutes
Exclusive interview with Terry Taylor, past president of The New Zealand Institute of Medical Laboratory Science (Inc.)
Dr. Lauren Murphy at the University of Oxford is investigating how platelets could hold the key to detecting cancer in patients with minimal residual disease